Lana Kandalaft, PhD University Medical School, Lausanne (CHUV)2019 Dearborn Family Pilot Study Award Development of personalized cancer vaccination strategies in ovarian cancer As ovarian cancer lacks specific symptoms, most patients are diagnosed at an advanced stage whereby treatment response is poor. One option for treatment is to activate the patient’s own immune system using individually […]
Read MoreStarting April 1, 2025, the Rivkin Center’s ovarian cancer research funding, global symposium and fundraising activities will continue under the leadership of Ovarian Cancer Research Alliance (OCRA).
